13 March 2014
3 February 2014
31 December 2013
Welcome in NeoMero
NeoMero project aims at adapting an off-patent medicine to the specific need of paediatric populations: in specific to evaluate PK, safety and efficacy of meropenem in comparison to standard care in late-onset sepsis and describe PK and safety in bacterial meningitis in neonates and infants aged less than 3 months in order to be able to register it for use in this age group with a PUMA.
This project has been funded with support by the European Commission under the FP7 programme, and has officially ended on 30th June 2015.
Reserved Access to the our services for our Partners.